<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Tyrosine metabolism" Version="20190121" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">This pathway shows the tyrosine degradation pathway as presented in Chapter 2 of the book of Blau (ISBN 3642403360 (978-3642403361)). Disorders resulting from an enzyme defect are highlighted in pink. Red frames mark diagnostically important metabolites. </Comment>
  <BiopaxRef>ac8</BiopaxRef>
  <Graphics BoardWidth="1425.9577300161302" BoardHeight="726.0"/>
  <DataNode TextLabel="quinol acetate" GraphId="a48a3" Type="Metabolite">
    <Comment>This compound is annotated with an example for quinol acetate (4-hydroxyphenyl acetate).</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Thiols" GraphId="c270f" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Hawkinsin" GraphId="e927b" Type="Metabolite">
    <Comment>aka 2-cystenyl-1,4-dihydroxycyclohexenylacetate</Comment>
    <BiopaxRef>c54</BiopaxRef>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Homogentisate" GraphId="fbd1e" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="[CO2]" GraphId="fce60" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="4-hydroxyphenylpyruvate hydroxylase" GraphId="d149d" Type="Protein">
    <Comment>HPD gene, with mutation p.Asn241Ser, leading to a change in function in the protein.</Comment>
    <BiopaxRef>db1</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Succinylacetone" GraphId="ab977" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="4-hydroxyphenylpyruvate dioxygenase" GraphId="cab4b" Type="Protein">
    <Comment>HPD gene, without mutation</Comment>
        </DataNode>
  <DataNode TextLabel="4-Maleylacetoacetate" GraphId="d089f" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Fumarylacetoacetase" GraphId="eb6d3" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Fumarate" GraphId="a90b0" Type="Metabolite" GroupRef="e0f78">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Acetoacetate" GraphId="a943b" Type="Metabolite" GroupRef="e0f78">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Homogentisate 1,2-dioxygenase" GraphId="f8694" Type="Protein">
        </DataNode>
  <DataNode TextLabel="4-Hydroxyphenylpyruvate" GraphId="aafd4" Type="Metabolite" GroupRef="d04d4">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="L-tyrosine" GraphId="be224" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="nitisone" GraphId="c121c" Type="Metabolite">
    <Comment>AKA NTBC</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Tyrosine aminotransferase" GraphId="f262b" Type="Protein">
        </DataNode>
  <DataNode TextLabel="4-Hydroxyphenylacetate" GraphId="c1422" Type="Metabolite" GroupRef="d04d4">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Succinylacetoacetate" GraphId="f6e79" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="4-fumarylacetoacetate(2-)" GraphId="a243b" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Porphobilinogen" GraphId="bbfe8" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="p-Hydroxyphenyllactate" GraphId="c0560" Type="Metabolite" GroupRef="d04d4">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="5-Aminolevulinate" GraphId="cda75" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <Interaction GraphId="id4da77879">
    <Comment>Change in reaction mechanism from 4-hydroxyphenylpyruvate froming quinol iso homogentisate.</Comment>
    <BiopaxRef>c54</BiopaxRef>
    <Graphics>
      <Point GraphRef="aafd4"/>
      <Point GraphRef="a48a3" ArrowHead="mim-conversion"/>
      <Anchor Position="0.43796328028810544" Shape="None" GraphId="bb04c"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id6c8de097">
    <BiopaxRef>c54</BiopaxRef>
    <Graphics>
      <Point GraphRef="a48a3"/>
      <Point GraphRef="e927b" ArrowHead="Arrow"/>
      <Anchor Position="0.7166818574027326" Shape="None" GraphId="c66ce"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idb0ac6f1">
    <BiopaxRef>c54</BiopaxRef>
    <Graphics>
      <Point GraphRef="c270f"/>
      <Point GraphRef="c66ce" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f5c66">
    <Graphics>
      <Point GraphRef="f6e79"/>
      <Point GraphRef="ab977" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="aecf0"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d001c" GroupRef="d04d4">
    <Graphics>
      <Point GraphRef="c0560"/>
      <Point GraphRef="aafd4" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b6e87">
    <Graphics>
      <Point GraphRef="f8694"/>
      <Point GraphRef="e89a4" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dea65">
    <Graphics>
      <Point GraphRef="a243b"/>
      <Point GraphRef="bf9b2" ArrowHead="mim-conversion"/>
      <Anchor Position="0.37309611344537785" Shape="None" GraphId="f9633"/>
      <Anchor Position="0.4" Shape="None"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fe910">
    <Graphics>
      <Point GraphRef="d089f"/>
      <Point GraphRef="f6e79" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e8cb2">
    <Graphics>
      <Point GraphRef="aafd4"/>
      <Point GraphRef="be224" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eb8f8">
    <Graphics>
      <Point GraphRef="a243b"/>
      <Point GraphRef="f6e79" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f0bec" GroupRef="d04d4">
    <Graphics>
      <Point GraphRef="aafd4"/>
      <Point GraphRef="c0560" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a2a0f">
    <Graphics>
      <Point GraphRef="f262b"/>
      <Point GraphRef="c87f8" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fa2d9" GroupRef="d04d4">
    <Graphics>
      <Point GraphRef="aafd4"/>
      <Point GraphRef="c1422" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dd274">
    <Graphics>
      <Point GraphRef="cab4b"/>
      <Point GraphRef="aa86b" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e050a">
    <Graphics>
      <Point GraphRef="aecf0"/>
      <Point GraphRef="fce60" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cf884">
    <Graphics>
      <Point GraphRef="ab977"/>
      <Point GraphRef="ef591" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c9c1d">
    <Graphics>
      <Point GraphRef="fbd1e"/>
      <Point GraphRef="d089f" ArrowHead="mim-conversion"/>
      <Anchor Position="0.3874804158951714" Shape="None" GraphId="e89a4"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a08ed" GroupRef="d04d4">
    <Graphics>
      <Point GraphRef="c1422"/>
      <Point GraphRef="aafd4" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d20a9">
    <BiopaxRef>db1</BiopaxRef>
    <Graphics>
      <Point GraphRef="d149d"/>
      <Point GraphRef="bb04c" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d18df">
    <Graphics>
      <Point GraphRef="cda75"/>
      <Point GraphRef="bbfe8" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="ef591"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e1078">
    <Graphics>
      <Point GraphRef="d089f"/>
      <Point GraphRef="a243b" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a510f">
    <Graphics>
      <Point GraphRef="eb6d3"/>
      <Point GraphRef="f9633" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ed4ff">
    <Graphics>
      <Point GraphRef="be224"/>
      <Point GraphRef="a1dd3" ArrowHead="mim-conversion"/>
      <Anchor Position="0.385319109638143" Shape="None" GraphId="c87f8"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fba06">
    <Graphics>
      <Point GraphRef="aafd4"/>
      <Point GraphRef="fbd1e" ArrowHead="mim-conversion"/>
      <Anchor Position="0.7489613294982421" Shape="None" GraphId="aa86b"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d2aa2">
    <Graphics>
      <Point GraphRef="c121c"/>
      <Point GraphRef="aa86b" ArrowHead="mim-inhibition"/>
    </Graphics>
    </Interaction>
  <GraphicalLine GraphId="a67a2">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="c87f8"/>
      <Point/>
      <Point GraphRef="cec3c" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c6844">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="aa86b"/>
      <Point/>
      <Point GraphRef="e662a" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="db829">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="bb04c"/>
      <Point/>
      <Point GraphRef="d03cc" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="bc1a8">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="f9633"/>
      <Point/>
      <Point GraphRef="e0f80" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ec36f">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="e89a4"/>
      <Point/>
      <Point GraphRef="d442b" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cfb79">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cf896">
    <Graphics LineStyle="Broken">
      <Point/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b9c02">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-catalysis"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ac24e">
    <Graphics>
      <Point/>
      <Point ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="Tyrosinaemia Type II" GraphId="cec3c" Href="https://www.omim.org/entry/276600">
    <Comment>AKA Tyrosine aminotransferase deficiency</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Hawkinsinuria (HAWK)" GraphId="d03cc" Href="https://www.omim.org/entry/140350">
    <Comment>AKA 4-hydroxyphenylpyruvate dioxygenase change of function</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Tyrosinaemia Type I" GraphId="e0f80" Href="https://www.omim.org/entry/276700">
    <Comment>AKA Fumarylacetoacetase deficiency</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Tyrosinaemia Type III" GraphId="e662a" Href="https://www.omim.org/entry/276710">
    <Comment>aka 4-hydroxyphenylpyruvate dioxygenase deficiency</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Alkaptonuria" GraphId="d442b" Href="https://www.omim.org/entry/203500">
    <Comment>AKA Homogentisate 1,2-dioxygenase deficiency</Comment>
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Disease" GraphId="bf35f">
    <Graphics FillColor="ffcccc" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Catalysis" GraphId="e997e">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Pathway" GraphId="f32da">
    <Graphics FillColor="ffffff" ShapeType="RoundedRectangle" Color="009933"/>
  </Label>
  <Label TextLabel="Stimulation" GraphId="df809">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Protein" GraphId="f2333">
    <Graphics FillColor="ffffff" ShapeType="Rectangle"/>
  </Label>
  <Label TextLabel="Metabolite" GraphId="b4ed2">
    <Graphics FillColor="ffffff" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Conversion" GraphId="f1a82">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Connection &#10;to disease&#10;" GraphId="bc849">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Legend" GraphId="ae486">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Biomarker" GraphId="ae388">
    <Graphics FillColor="ffffff" ShapeType="Rectangle" Color="0000ff"/>
  </Label>
  <Shape GraphId="dd60e">
    <Graphics ShapeType="Rectangle" Color="ff0033"/>
  </Shape>
  <Shape GraphId="ed1d3">
    <Graphics ShapeType="Rectangle" Color="ff0033"/>
  </Shape>
  <Shape GraphId="a1dd3" GroupRef="d04d4">
    <Graphics ShapeType="Rectangle" Color="ff0033"/>
  </Shape>
  <Shape GraphId="a0cab">
    <Graphics ShapeType="Rectangle" Color="ff0033"/>
  </Shape>
  <Shape GraphId="dfe0d">
    <Graphics ShapeType="RoundedRectangle" LineStyle="Broken" Color="c0c0c0"/>
  </Shape>
  <Shape GraphId="f3f2d">
    <Graphics ShapeType="Rectangle" Color="ff0033"/>
  </Shape>
  <Group GroupId="d04d4" GraphId="b14da" Style="Group"/>
  <Group GroupId="e0f78" GraphId="bf9b2" Style="Group"/>
  <InfoBox/>
  <Biopax>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >tyrosinemia type III</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:0050727</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ac8">
      <bp:ID >9783642403361</bp:ID>
      <bp:DB >ISBN</bp:DB>
      <bp:TITLE >Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases</bp:TITLE>
      <bp:SOURCE />
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Blau, Nenad</bp:AUTHORS>
      <bp:AUTHORS >Duran, Marinus</bp:AUTHORS>
      <bp:AUTHORS >Gibson, K. Michael</bp:AUTHORS>
      <bp:AUTHORS >Dionisi-Vici, Carlo</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c54">
      <bp:ID >20677779</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simple route to the treatment of Hawkinsinuria.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:ID >20677779</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simple route to the treatment of Hawkinsinuria.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:ID >20677779</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simple route to the treatment of Hawkinsinuria.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:ID >20677779</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simple route to the treatment of Hawkinsinuria.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:ID >20677779</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simple route to the treatment of Hawkinsinuria.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:ID >20677779</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simple route to the treatment of Hawkinsinuria.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:AUTHORS >Brownlee JM</bp:AUTHORS>
      <bp:AUTHORS >Heinz B</bp:AUTHORS>
      <bp:AUTHORS >Bates J</bp:AUTHORS>
      <bp:AUTHORS >Moran GR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >tyrosinemia type II pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001609</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >tyrosinemia type I pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001608</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >tyrosinemia type I</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:0050726</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >tyrosinemia type II</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:0050725</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >alkaptonuria pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0002277</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >inherited metabolic disorder</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:655</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >tyrosine degradation pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001284</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >alkaptonuria</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:9270</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >tyrosine metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000052</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >tyrosinemia type III pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001610</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >tyrosinemia pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0001607</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="db1">
      <bp:ID >17560158</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III.</bp:TITLE>
      <bp:SOURCE >Mol Genet Metab</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Item CB</bp:AUTHORS>
      <bp:AUTHORS >Mihalek I</bp:AUTHORS>
      <bp:AUTHORS >Lichtarge O</bp:AUTHORS>
      <bp:AUTHORS >Jalan A</bp:AUTHORS>
      <bp:AUTHORS >Vodopiutz J</bp:AUTHORS>
      <bp:AUTHORS >Muhl A</bp:AUTHORS>
      <bp:AUTHORS >Bodamer OA</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>